Clinical trial
Assessment of Onset, Safety & Toleration of UK-369,003 in Male Erectile…
NCT00141349 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00141349 |
|---|---|
| Title | Assessment of Onset, Safety & Toleration of UK-369,003 in Male Erectile Dysfunction |
| Official title | A Double-Blind, Placebo Controlled, Parallel Group, Multicenter Study to Assess the Time to Onset, Safety, and Toleration of Differing Doses and Combinations of Immediate Release and Modified Release Formulations of UK369,003 in Adult Male Subject With Erectile Dysfunction |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Impotence |
| Intervention type | Drug |
| Interventions | UK-369, 003 |
| Enrollment | 300 |
| Start date | Feb 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Sep 1, 2005 |
| Last update posted | Jul 25, 2006 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: